Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million on December 27, 2022. The transaction was approved by Zhejiang Huakang Pharmaceutical Co., Ltd. twenty-sixth meeting of the fifth board of directors. For the year ended, October 31, 2022, total asset is CNY 192.68 million and Owners equity is CNY 163.42 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.63 CNY | +1.36% | -4.81% | -6.10% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.10% | 641M | |
-6.56% | 27.18B | |
+21.63% | 25.15B | |
+6.15% | 11.14B | |
+11.82% | 5.12B | |
+12.04% | 4.21B | |
-14.44% | 3.56B | |
+3.57% | 3.44B | |
-4.91% | 2.83B | |
+24.97% | 2.76B |
- Stock Market
- Equities
- 605077 Stock
- News Zhejiang Huakang Pharmaceutical Co., Ltd.
- Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million.